BINGO: Bridging Knowledge, Increasing Awareness

NCT ID: NCT06504407

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-28

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The U.S. population is becoming more diverse, but minority groups are still significantly underrepresented in cancer clinical trials. This disparity limits our understanding of how treatments work across different populations. Efforts like the 21st Century Cures Act aim to improve inclusion, but challenges persist due to historical mistrust and complex barriers in healthcare.

To address these issues, Penn State Health is using a fun and educational approach called "BINGO" to engage the African American/Black community in Dauphin and surrounding counties. Led by the PSCI Diversity Navigator, these BINGO games will provide information about cancer and clinical trials in a relaxed setting. The goal is to build trust, increase awareness, and ultimately improve participation of underrepresented groups in clinical trials.

Through this initiative, they hope to connect participants with needed healthcare services and gather feedback to tailor future trials to community needs. This approach aims to foster collaboration between minority communities and the healthcare system, ensuring that clinical trials reflect the diversity of the population they aim to serve.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Penn State Health is addressing the underrepresentation of minority groups in cancer clinical trials through a community-engagement initiative using a BINGO educational game. Despite efforts like the 21st Century Cures Act, minority participation remains low, impacting the generalizability of trial results and access to novel treatments for diverse populations.

Led by the PSCI Diversity Navigator, this initiative focuses on the African American/Black community in Dauphin and surrounding counties. The BINGO games serve as a platform to educate participants about cancer, clinical trials, and the importance of diversity in research. By creating a relaxed and enjoyable atmosphere, the initiative aims to build trust and increase awareness among community members.

The project's long-term goals include fostering collaboration between minority communities and Penn State Health, improving clinical trial participation rates among underrepresented populations, and addressing healthcare disparities. Immediate objectives involve assessing the feasibility, educational utility, and engagement of the BINGO game through pre- and post-game surveys and knowledge tests.

Recruitment efforts target community centers and organizations like historically Black sororities and churches, leveraging their influence and trust within the community. The initiative strategically focuses on areas with high African American populations, such as Harrisburg, to maximize impact and engagement.

Feedback gathered from participants will guide future trial designs tailored to community needs, enhancing the inclusivity and relevance of research efforts. By promoting understanding and trust, Penn State Health aims to create a model that can be replicated to improve minority participation in clinical trials nationwide.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Education Health Equity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single arm interventional study
Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bingo Educational Intervention

Single-arm, interventional study where all participants will engage in the Bingo game as an educational intervention.

Group Type EXPERIMENTAL

Bingo Educational Game

Intervention Type BEHAVIORAL

The intervention involves Bingo games designed to educate African American/Black community members about cancer and clinical trials. During each game, educational facts are shared, and prizes promoting healthy lifestyles are awarded. Led by a Diversity Navigator, the sessions include pre- and post-test surveys to assess knowledge gain and engagement. The intervention also connects participants with needed medical services.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bingo Educational Game

The intervention involves Bingo games designed to educate African American/Black community members about cancer and clinical trials. During each game, educational facts are shared, and prizes promoting healthy lifestyles are awarded. Led by a Diversity Navigator, the sessions include pre- and post-test surveys to assess knowledge gain and engagement. The intervention also connects participants with needed medical services.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age: Adults aged 18 years and above.
2. Gender Identity: Individuals identifying as cisgender, transgender, or females.
3. Language Proficiency: Proficiency in English equivalent to middle school/high school level.
4. Registration: Completion of registration via the provided RedCap link prior to the Bingo session.
5. Consent: Willingness to provide written consent at the beginning of the Bingo session to participate in the research study.

Exclusion Criteria

1. Age: Individuals under the age of 18 years.
2. Gender Identity: Participants who do not identify as cisgender, transgender, or females.
3. Language Proficiency: Inability to understand English at a middle school/high school level.
4. Previous Participation: Individuals who have already participated in a previous Bingo game session for this study.
5. Medical or Cognitive Impairment: Participants unable to provide informed consent or actively participate due to medical or cognitive reasons.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Milton S. Hershey Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Monali Vasekar

Assistant Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Monali Vasekar, MD

Role: PRINCIPAL_INVESTIGATOR

Penn State Cancer Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Penn State Cancer Institute

Hershey, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Monali Vasekar

Role: CONTACT

7175318678

Xin Liu, Ph.D

Role: CONTACT

7175313073

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vasekar

Role: primary

7175318678

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PSCI-24-021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.